4.7 Article

Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions

Enzo Spisni et al.

Summary: There is increasing interest in the pharmaceutical industry regarding the human intestinal microbiota due to its association with non-communicable diseases. While probiotics and prebiotics have been explored for modulating the gut microbiota, this review highlights other potential interventions such as postbiotics, essential oils, fungus, and officinal plants. Further research, especially clinical studies using fungus, officinal and aromatic plants or their extracts, is necessary to fully understand and harness the potential of these interventions in modulating the intestinal microbiota for improved pharmacological therapy of non-communicable diseases.

FRONTIERS IN PHARMACOLOGY (2022)

Article Gastroenterology & Hepatology

Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

Ami D. Sperber et al.

Summary: FGIDs have a high prevalence globally, especially among women. Individuals with FGIDs experience lower quality of life and require more frequent medical visits. The proportion of irritable bowel syndrome patients diagnosed using the Rome IV criteria is lower compared to the Rome III criteria.

GASTROENTEROLOGY (2021)

Review Nutrition & Dietetics

Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier

Giovanni Barbara et al.

Summary: The intestinal epithelial barrier plays a crucial role in maintaining homeostasis by controlling the passage of nutrients and harmful substances. Tight junctions are responsible for regulating paracellular permeability and maintaining barrier integrity. Factors like cytokines, gut microbiota, and dietary components influence the function of intestinal TJs, highlighting their importance in various diseases such as IBS, IBD, and gluten-related conditions.

FRONTIERS IN NUTRITION (2021)

Article Gastroenterology & Hepatology

Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?

Ruben A. T. Mars et al.

Summary: Human studies have shown links between the intestinal microbiome and functional gastrointestinal disorders (FGIDs), but there is often a gap between human and animal research, hindering the translation of microbiome findings to clinical practice. Changes in microbial function reflected in the fecal metabolome may be more precise indicators of disease subtype-specific mechanisms. Further longitudinal studies in both humans and animals are needed to effectively determine microbial functions that can address specific pathophysiological processes in FGIDs.

GASTROENTEROLOGY (2021)

Article Health Care Sciences & Services

Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components

Zahra A. Barandouzi et al.

Summary: The study compared food components and gut microbiota patterns between IBS patients and healthy controls, finding higher alpha diversity indices and altered gut microbiota in IBS patients. High microbial diversity and alterations in gut microbiota composition were observed in IBS individuals with high caffeine consumption, suggesting a potential link between caffeine intake and gut microbiome patterns.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Medicine, General & Internal

Diagnosis and Treatment of Irritable Bowel Syndrome

Michael Camilleri

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Gastroenterology & Hepatology

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

Dipesh H. Vasant et al.

Summary: This guideline aims to review and summarize current evidence on irritable bowel syndrome (IBS) to inform clinical practice and provide guidance, with specific treatment recommendations based on evidence from a comprehensive search of medical literature. The guideline highlights the efficacy of dietary, pharmacological, and psychological therapies in treating IBS, and provides specific recommendations according to the Grading of Recommendations Assessment, Development, and Evaluation system.
Article Nutrition & Dietetics

Oregano Essential Oils Promote Rumen Digestive Ability by Modulating Epithelial Development and Microbiota Composition in Beef Cattle

Rui Zhang et al.

Summary: This study found that supplementation of oregano essential oils (OEO) can enhance rumen digestive ability in cattle by modulating epithelial development and microbiota composition. High dose of OEO led to longer rumen papillae, increased relative abundance of propionate and butyrate, and changes in enzyme concentrations.

FRONTIERS IN NUTRITION (2021)

Article Gastroenterology & Hepatology

Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial

Judy Nee et al.

Summary: This study compared the effects of peppermint oil vs placebo in relieving IBS symptoms and found both groups showed clinically meaningful improvement, but there were no significant differences between them. Further large, rigorous trials are needed to evaluate the role of peppermint oil for treating IBS.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Pediatrics

Low-Dose Antibiotic Prophylaxis Induces Rapid Modifications of the Gut Microbiota in Infants With Vesicoureteral Reflux

William Morello et al.

Summary: In this study, the gut microbiota composition of infants with vesicoureteral reflux was significantly altered by short-term exposure to continuous low-dose antibiotic prophylaxis (CAP), leading to an increase in opportunistic pathogens and a decrease in health-promoting bacteria. Conversely, infants not exposed to CAP had a gut microbiota primarily enriched in Bifidobacterium. These findings suggest that early antibiotic exposure in infants may have potential long-term clinical risks.

FRONTIERS IN PEDIATRICS (2021)

Article Gastroenterology & Hepatology

Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome

Zsa Zsa R. M. Weerts et al.

GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity

Maria Raffaella Barbaro et al.

Editorial Material Gastroenterology & Hepatology

Faecal microbial transplantation in IBS: ready for prime time?

Giovanni Barbara et al.

Article Biochemistry & Molecular Biology

Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome

Ruben A. T. Mars et al.

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

Gianluca Ianiro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Microbiology

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease

Alessandra Lo Presti et al.

FRONTIERS IN MICROBIOLOGY (2019)

Review Gastroenterology & Hepatology

Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis

Kanchana Myneedu et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)

Article Chemistry, Multidisciplinary

Effect of Geraniol and Citronellol Essential Oils on the Biophysical Gating Properties of AMPA Receptors

Mohammad Qneibi et al.

APPLIED SCIENCES-BASEL (2019)

Article Chemistry, Medicinal

Microbiota-Host Transgenomic Metabolism, Bioactive Molecules from the Inside

Silvia Turroni et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Engineering, Biomedical

Irritable bowel syndrome - from etiopathogenesis to therapy

Biljana Radovanovic-Dinic et al.

BIOMEDICAL PAPERS-OLOMOUC (2018)

Article Pharmacology & Pharmacy

Pre- and probiotic overview

Cesare Cremonl et al.

CURRENT OPINION IN PHARMACOLOGY (2018)

Article Microbiology

Intestinal Microbiome-Metabolome Responses to Essential Oils in Piglets

Yuan Li et al.

FRONTIERS IN MICROBIOLOGY (2018)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

Alexander C. Ford et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Article Integrative & Complementary Medicine

Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study

Fernando Rizzello et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)

Review Gastroenterology & Hepatology

Probiotics in irritable bowel syndrome: Where are we?

Giovanni Barbara et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2018)

Review Pharmacology & Pharmacy

Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders

Diego Curro et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Review Gastroenterology & Hepatology

Irritable bowel syndrome: a gut microbiota-related disorder?

Yogesh Bhattarai et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)

Article Nursing

Irritable Bowel Syndrome

Kristen Ronn Weaver et al.

AMERICAN JOURNAL OF NURSING (2017)

Letter Gastroenterology & Hepatology

Gut microbiota composition associated with stool consistency

E. F. Tigchelaar et al.

Article Gastroenterology & Hepatology

The Intestinal Microenvironment and Functional Gastrointestinal Disorders

Giovanni Barbara et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Bowel Disorders

Brian E. Lacy et al.

GASTROENTEROLOGY (2016)

Article Biochemical Research Methods

DADA2: High-resolution sample inference from Illumina amplicon data

Benjamin J. Callahan et al.

NATURE METHODS (2016)

Article Multidisciplinary Sciences

VSEARCH: a versatile open source tool for metagenomics

Torbjorn Rognes et al.

Article Microbiology

Insights into the Role of Erysipelotrichaceae in the Human Host

Nadeem O. Kaakoush

Frontiers in Cellular and Infection Microbiology (2015)

Letter Gastroenterology & Hepatology

Is Fecal Microbiota Transplantation the Answer for Irritable Bowel Syndrome? A Single-Center Experience

David M. Pinn et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Manipulation of the Microbiota for Treatment of IBS and IBD-Challenges and Controversies

Fergus Shanahan et al.

GASTROENTEROLOGY (2014)

Review Gastroenterology & Hepatology

A role for the gut microbiota in IBS

Stephen M. Collins

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Review Gastroenterology & Hepatology

Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report

Douglas A. Drossman et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

Mirjana Rajilic-Stojanovic et al.

GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome

Erja Malinen et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Article Biochemistry & Molecular Biology

Natural terpenes: Self-assembly and membrane partitioning

A. del V. Turina et al.

BIOPHYSICAL CHEMISTRY (2006)